TABLE 7 Estimated Outcomes as a Function of IMR, estimated from linear mixed models in the Completers sample Baseline Post treatment (12 months) Follow-up (18 months) Mean difference Mean difference Mean difference N Mean (95% CI) (95% CI) d N Mean (95% CI) (95% CI) d N Mean (95% CI) (95% CI) d PRIMARY OUTCOME IMRS client version Experimental 57 3.36 (3.23, 3.50) 0.08 (-0.09, 0.25) 0.16 53 3.56 (3.43, 3.69) 0.19 (0.01, 0.37) 0.38 54 3.65 (3.53,3.77) 0.27 (0.10, 0.44) 0.59* Control 71 3.29 (3.18, 3.39) 58 3.37 (3.24, 3.50) 58 3.38 (3.26, 3.50) SECONDARY OUTCOMES IMRS clinician version Experimental 57 3.29 (3.19, 3.39) 0.08 (-0.05, 022) 0.21 53 3.63 (3.52, 3.74) 0.33 (0.18, 0.48) 0.79 54 3.67 (3.55, 3.79) 0.29 (0.12, 0.47) 0.62* Control 71 3.20 (3,11, 3.30) 61 3.30 (3.20, 3.41) 54 3.37 (3.24, 3.50) MSPSS Experimental 57 5.02 (4.65, 5.39) 0.32 (-0.19, 0.84) 0.22 53 5.28 (4.97, 5.59) 0.56 (0.08, 1.05) 0.43 54 5.33 (4.99, 5.67) 0.43 (-0.05, 0.91) 0.33 Control 70 4.70 (4.34, 5.06) 58 4.72 (4.34, 5.09) 58 4.90 (4.57, 5.24) CSES Experimental 57 131.04 (117.96, 144.11) 0.26 (-17.41, 17.92) 0.01 53 144.12 (133.07, 155.17) 12.72 (-3.23, 28.68) 0.28 54 146.19 (134.75, 157.64) 11.51 (-4.58, 27.60) 0.26 Control 71 130.78 (118.91, 142.65) 58 131.40 (119.89, 142.90) 58 134.68 (123.37, 145.99) SES Experimental 56 11.09 (10.62, 11.56) 0.30 (-0.34, 0.95) 0.16 53 11.18 (10.81, 11.55) 0.60 (-0.03, 1.24) 0.34 54 11.26 (10.81, 11.71) 0.53 (-0.13, 1.20) 0.31 Control 71 10.79 (10.34, 11.24) 60 10.57 (10.06, 11.09) 54 10.72 (10.24, 11.21) IS Experimental 57 10.06 (9.39, 10.73) 0.64 (-0.39, 1.67) 0.21 53 10.18 (9.61, 10.76) 0.39 (-0.56, 1.35) 0.15 54 10.07 (9.35, 10.78) 0.48 (-0.61, 1.56) 0.16 Control 70 9.41 (8.63, 10.20) 57 9.79 (9.02, 10.56) 57 9.59 (8.77, 10.41) ASI Experimental 57 0.40 (0.14, 0.67) -0.05 (-0.41, 0.32) -0.04 53 0.34 (0.10, 0.59) 0.00 ('-0.32, 032) 0.00 54 0.29 (-0.03, 0.60) -0.11 (-0.50, 0.28) -0.11 Control 71 0.45 (0.20, 0.70) 58 0.35 (0.15, 0.54) 57 0.40 (0.16, 0.63) BSI Experimental 57 1.23 (1.03, 1.44) -0.09 (-0.37, 0.20) -0.11 53 1.10 (0.88, 1.31) -0.23 (-0.53, 0.07) -0.27 54 1.12 (0.91, 1.33) -0.12 (-0.42, 0.17) -0.15 Control 71 1.32 (1.12, 1.52) 58 1.33 (1.12, 1.54) 58 1.24 (1.04, 1.45) SFS Experimental 57 104.48 (102.19, 106.77) -0.39 (-3.39, 2.62) -0.05 53 106.42 (104.25, 108.58) 1.92 (-1.03, 4.87) 0.23 54 107.31 (106.13, 109.49) 1.45 (-1.64, 4.53) 0.17 Control 71 104.87 (102.92, 106.81) 58 104.50 (102.49, 106.50) 58 105.86 (103.68, 108.05) MHRM Experimental 57 69.04 (63.43, 74.65) 0.08 (-7.07, 7.23) 0.00 53 72.86 (67.33, 78.39) 5.15 (-2.15, 12.45) 0.25 54 73.48 (69.02, 77.94) 5.79 (-0.86,12.45) 0.32* Control 71 68.96 (64.53, 73.40) 58 67.71 (62.94, 74.49) 58 67.68 (62.75, 72.62) SERS-SF Experimental 57 11.76 (5.80, 17.72) 4.85 (-3.31, 13.01) 0.16 53 16.81 (10.76, 22.85) 11.54 (3.70, 19.38) 0.53 54 16.88 (10.60, 23.16) 12.13 (4.01, 20.26) 0.54* Control 71 6.91 (1.33, 12.49) 58 5.72 ( 0.27, 10.26) 58 4.75 (-0.42, 9.91) ISMI Experimental 57 2.10 (1.97, 2.22) -0.06 (-0.24, 0.12) -0.12 53 1.98 (1.86, 2.10) -0.23 (-0.40, -0,06) -0.48 54 1.99 (1.86, 2.12) -0.17 (-0.35,0.01) -0.34 Control 71 2.16 (2.03, 2.28) 58 2.21 (2.08, 2.33) 58 2.16 (2.03, 2.28) * A treatment effect was found on this variable as reported in Table 6. IMRS= Illness Management and Recovery scale; MSPSS= Multidimensional Scale of Perceived Social Support. CSES= Coping SelfEfficacy Scale. SES= Service Engagement Scale, subscale treatment adherence; IS= Insight Scale. ASI= Addiction Severity Index, item 24. BSI = Brief Symptom Inventory. SFS= Social Functioning Scale. MHRM= Mental Health Recovery Measure. SERS-SF = Self-Esteem Rating Scale-Short Form. ISMI= Internal Stigma of Mental Illness.
RkJQdWJsaXNoZXIy MjY0ODMw